What strategic investments is John Shubert and Steve Forbes recommending to reduce fee structure in 401k accounts?
Microblogs
September 11, 2013
Navellier Comments 9/10/13
Travis or Gumshoe Irregulars: Can you test the thinkolater for this play? Anyone else have an idea what company he is pitching? ”But other than the AAPL pure play, I just recommended that my Emerging Growth subscribers initiate a position in a practically unknown Chinese company that is tripling its sales after recently having won […]
Recent Author Comments
Posted on December 18, 2018
Posted on November 17, 2018
Good call on IIPR Travis. So glad we have your expertise to make knowledgeable decisions on your articles. Happy Thanksgiving to the Gumshoe family.[...]
Posted on January 27, 2018
APTO Staying Firm and Long per Docs prediction. Have a great weekend all!Dr. KSS MD PhD Agree. I think that to pierce $4 and stay there, it needs a catalyst— which will be formal FDA lifting of the APTO-253 hold. I predict that will come during the [...]
Posted on August 7, 2017
Much appreciated Helen. Thank you for the clarification on the SAR index.I have not sold any AUPH shares much like you and bought the dips. Good management and strong science.[...]
Posted on August 7, 2017
Just curious as to Helen's Parabolic SAR #'s as it relates to AUPH. I believe the SAR target # was $6.12. AUPH now trending around $6.02. Should we be reading more into these SAR numbers? I have learned so much from the Gummies, Travis, Helen, Cleveland a[...]
Posted on February 26, 2017
Tim:Thoughts and prayers for you and your family. Stay strong.[...]
Posted on January 23, 2017
HN: Many thanks for Ivanhoe and PVG. Hanging on there with SAND. Your due diligence and hard work is appreciated.[...]
Posted on July 19, 2016
Your team's hard work is very appreciated Travis.[...]
Posted on May 16, 2016
Thanks Doc. I figured you knew them or heard of them. Much appreciated,[...]
Posted on May 16, 2016
This is the first paragraph relating to the Duke scientists discovery.“A bold experiment to kill a vicious cancer has won breakthrough status from the Food and Drug Administration. Early tests at Duke University have been so successful the FDA will f[...]
Posted on May 16, 2016
This is the first paragraph relating to the Duke scientists discovery."A bold experiment to kill a vicious cancer has won breakthrough status from the Food and Drug Administration. Early tests at Duke University have been so successful the FDA will fas[...]
Posted on May 16, 2016
Dr. Kss: Any idea what company that have licensed this?http://www.cbsnews.com/news/60-minutes-fda-breakthrough-status-duke-university-cancer-therapy/[...]
Posted on January 30, 2016
Thanks Glenn[...]
Posted on January 29, 2016
ESPR Investor Alert: Hardly good newsINVESTOR ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Esperion Therapeutics, Inc. of Class Action Lawsuit and a Lead Plaintiff Deadline of March 14, 2016 – ESPR NEW YORK, NY / ACCESSWIRE / January 25, 20[...]
Posted on January 13, 2016
HALO Info.....Finally, there’s Halozyme Therapeutics, Inc. (NASDAQ:HALO), the only small-cap in this list, which has lost about 15% in Wednesday trading. The stock has been plummeting consistently this year, having lost almost 40% in 2016, losing much of[...]
Posted on October 21, 2015
Hillary's attack on the drug companies has created some great buying opportunities since the Bio tech sector has cratered. I am long many of the stocks suggested in Gumshoeland but wondering if they all will survive this onslaught. Politicians $#@*&^+###.[...]
Posted on October 7, 2015
HN: Can non smokers sign up for your program? -------------------------------------------------------------------------------------- Re: Trans Pacific Partnership Trade deal with Japan and 10 other countries can also effect American Drug Companies . We h[...]
Posted on October 6, 2015
IBB down 8% today. Biotechs are getting slammed. As stated above, the whole sector is being pillaged. A real drug war is playing out from a cost perspective. Any idea when the carnage will stop.[...]
Posted on September 29, 2015
ESPR testing original purchase I made at $15.50. Ready for the next run just like the first one to happen. Bought additional shares. FDA seems to be hesitant to move forward in this arena letting the recently approved cholesterol drugs get some traction. [...]
Posted on September 21, 2015
Like to believe the selloff is due to Clinton bashing healthcare drugs but wonder if something bigger isn't lurking around the corner that will affect all stocks in early October. Like most, I am fully invested in many of the recommendations made on this [...]
We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.
More Info Please note that this is your publicly visible biography - we recommend not including any personal information (phone, email, address, etc.) and ONLY linking to any other pages or profiles you're comfortable sharing with everyone.
With all this extreme volatility hearing from you more often is reassuring Travis.[...]